Fatal factors of clinical manifestations and laboratory testing in patients with amniotic fluid embolism

Gynecologic and Obstetric Investigation

Volumn 70, Issue 2, 2010, Pages 138-144

  Oi, Hidekazu ^a   Naruse, Katsuhiko ^a   Noguchi, Taketoshi ^a   Sado, Toshiyuki ^a   Kimura, Satoshi ^b   Kanayama, Naohiro ^b   Terao, Toshihiko ^b   Kobayashi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amniotic fluid embolism; Amniotic fluid embolism registry; Fatal factor; Obstetric emergency; Sialyl Tn

Indexed keywords

ADULT; AMNION FLUID EMBOLISM; ARTICLE; CESAREAN SECTION; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DYSPNEA; FATALITY; FEMALE; GESTATION PERIOD; HEART ARREST; HUMAN; LABOR COMPLICATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; EMBOLISM, AMNIOTIC FLUID; FEMALE; HEART ARREST; HUMANS; JAPAN; MECONIUM; OBSTETRIC LABOR COMPLICATIONS; PREGNANCY; PROGNOSIS; REGISTRIES; RISK FACTORS; YOUNG ADULT;

EID: 77951251388     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313302     Document Type: Article

References (27)

1. Benson MD: Anaphylactoid syndrome of pregnancy. Am J Obstet Gynecol 1996; 175: 749.
2. Benson MD, Lindberg RE: Amniotic fluid embolism, anaphylaxis, and tryptase. Am J Obstet Gynecol 1996; 175: 737.
3. Clark SL, Hankins GDV, Dudley DA, Dildy GA, Porter TF: Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995; 172: 1158-1169.
4. Kramer MS, Rouleau J, Baskett TF, Joseph KS: Maternal Health Study Group of the Canadian Perinatal Surveillance System. Amniotic-fluid embolism and medical induction of labour: a retrospective, population- based cohort study. Lancet 2006; 368: 1444-1448.
5. Gilbert WM, Danielsen B: Amniotic fluid embolism: decreased mortality in a population- based study. Obstet Gynecol 1999; 93: 973-977.
6. Abenhaim HA, Azoulay L, Kramer MS, Leduc L: Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol 2008; 199: 49e1-49e8.
7. Morgan M: Amniotic fluid embolism. Anaesthesia 1979; 34: 20-32.
8. Tuffnell DJ: United Kingdom amniotic fluid embolism register. BJOG 2005; 112: 1625-1629.
9. Kobayashi H, Ohi H, Terao T: A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc α2- 6GalNac. Am J Obstet Gynecol 1993; 168: 848-853.
10. Horiuchi K, Adachi K, Fujise Y, Naruse H, Sumimoto K, Kanayama N, Terao T: Isolation and characterization of zinc coproporphyrin I: a major fluorescent component in meconium. Clin Chem 1991; 37: 1173-1177.
11. Kanayama N, Yamazaki T, Naruse H, Sumimoto K, Horiuchi K, Terao T: Determining Zinc coproporphyrin in maternal plasma - a new method for diagnosing amniotic fluid embolism. Clin Chem 1992; 38: 526-529.
12. Benson MD: Nonfatal amniotic fluid embolism. Three possible cases and a new clinical definition. Arch Fam Med 1993; 2: 989-994.
13. Margarson MP: Delayed amniotic fluid embolism following caesarean section under spinal anaesthesia. Anaesthesia 1995; 50: 804-806.
14. Malhotra P, Agarwal R, Awasthi A, Das A, Behera D: Delayed presentation of amniotic fluid embolism: lessons from a case diagnosed at autopsy. Respirology 2007; 12: 148-150.
15. Courtney LD: Coagulation failure in pregnancy. BMJ 1970; 1: 691.
16. Spiliopoulos M, Puri I, Jain NJ, Kruse L, Mastrogiannis D, Dandolu V: Amniotic fluid embolism-risk factors, maternal and neonatal outcomes. J Matern Fetal Neonatal Med 2009; 22: 439-444.
17. Lau G, Chui PP: Amniotic fluid embolism: a review of 10 fatal cases. Singapore Med J 1994; 35: 180-183.
18. Oi H, Kobayashi H, Hirashima Y, Yamazaki T, Kobayashi T, Terao T: Serological and immunohistochemical diagnosis of amniotic fluid embolism. Semin Thromb Hemost 1998; 24: 479-484.
19. Fineschi V, Riezzo I, Cantatore S, Pomara C, Turillazzi E, Neri M: Complement C3a expression and tryptase degranulation as promising histopathological tests for diagnosing fatal amniotic fluid embolism. Virchows Arch 2009; 454: 283-290.
20. Benson MD, Kobayashi H, Silver RK, Oi H, Greenberger PA, Terao T: Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 2001; 97: 510-514.
21. Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique NM, Alving CR, Muggia FM: Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol 2003; 14: 1430-1437.
22. Pazdur R, Kudelka AP, Kavanagh JJ, Cohen PR, Raber MN: The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere). Cancer Treat Rev 1993; 19: 351-386.
23. Szebeni J: Complement activation-related pseudoallergy: a new class of drug- induced acute immune toxicity. Toxicology 2005; 216: 106-121.
24. Hammerschmidt DE, Ogburn PL, Williams JE: Amniotic fluid activates complement. A role in amniotic fluid embolism syndrome? Lab Clin Med 1984; 104: 901-907.
25. Harboe T, Benson MD, Oi H, Softeland E, Bjorge L, Guttormsen AB: Cardiopulmonary distress during obstetrical anaesthesia: attempts to diagnose amniotic fluid embolism in a case series of suspected allergic anaphylaxis. Acta Anaesthesiol Scand 2006; 50: 324-330.
26. Fineschi V, Gambassi R, Gherardi M, Turillazzi E: The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase. Int J Legal Med 1998; 111: 238-243.
27. Nishio H, Matsui K, Miyazaki T, Tamura A, Iwata M, Suzuki K: A fatal case of amniotic fluid embolism with elevation of serum mast cell tryptase. Sci Int 2002; 126: 53-56.